First National Bank of Omaha Purchases New Stake in Danaher Corporation $DHR

Key Points

• First National Bank of Omaha purchased 11,454 Danaher shares in the second quarter, valued at approximately $8.25 million. Institutional investors collectively own 79.05% of the company, with several major firms also initiating or expanding positions.
• Danaher reported quarterly EPS of $1.94, exceeding estimates of $1.85, while revenue reached $6.26 billion and rose 5.5% year over year.
• Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus and an average price target of $228.91, compared with shares trading near $199.62.

First National Bank of Omaha acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 11,454 shares of the conglomerate's stock, valued at approximately $8,247,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Danaher in the second quarter worth approximately $10,492,520,000. Norges Bank purchased a new position in Danaher during the fourth quarter valued at approximately $2,177,106,000. Bank of New York Mellon Corp purchased a new position in Danaher during the second quarter valued at approximately $712,875,000. Viking Global Investors LP increased its stake in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate's stock valued at $574,351,000 after buying an additional 2,455,994 shares during the period. Finally, Deutsche Bank AG purchased a new stake in Danaher in the 2nd quarter worth approximately $446,265,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

Shares of NYSE:DHR opened at $199.62 on Wednesday. The business has a fifty day moving average of $193.74 and a 200-day moving average of $192.50. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The firm has a market cap of $140.33 billion, a PE ratio of 35.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 EPS. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on DHR shares. HSBC dropped their price target on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research note on Wednesday, June 3rd. UBS Group lowered their price objective on Danaher from $270.00 to $250.00 and set a "buy" rating on the stock in a report on Wednesday, April 22nd. Evercore reiterated an "outperform" rating and issued a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They set a "buy" rating and a $230.00 price target for the company. Finally, Argus lowered their target price on Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and an average price target of $228.91.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source